What is the typical titer range of your standard AAV packaging?

We guarantee titers of ≥1×10¹² GC/mL with high purity and low endotoxin levels.

Which AAV serotypes do you offer?

We provide AAV1, AAV2, AAV5, AAV6, AAV7, AAV8, AAV9, and more upon request.

How do you ensure quality control for AAV packaging?

We perform qPCR, ELISA, sterility testing, and functional transduction assays.

Can you produce custom AAV vectors for specific applications?

Yes, we offer AI-enhanced custom AAV variant design and packaging.

How long does it take to receive my AAV vectors?

Standard orders ship as fast as 2 weeks, and custom projects may take 5-6 weeks.

High-Purity AAV Packaging for Gene Therapy Research

Standard AAV Packaging

Cyagen offers high-purity, high-titer AAV vectors for gene therapy and in vivo research. Our optimized three-plasmid system ensures high infection efficiency, low endotoxin levels, and broad serotype compatibility.

Fast & Reliable Delivery

Standard AAV projects ship in as fast as 2 weeks with rigorous QC testing.

Broad Serotype Selection

Offers multiple serotypes for different tissues and applications.

High Purity & Titer

Achieves robust gene expression in dividing and non-dividing cells.

Overview

Workflow

FAQs

Overview

High-Quality AAV Packaging for Gene Therapy

Adeno-associated virus (AAV) vectors are the most widely used viral vectors for gene therapy due to their low immunogenicity, stable expression, and ability to transduce both dividing and non-dividing cells.

Cyagen offers a reliable AAV packaging service with guaranteed high purity, titer, and quality control. Our production process ensures that researchers can receive ready-to-use viral vectors optimized for in vivo and in vitro applications.

Enhancing AAV Gene Delivery: A Case Study in Optimized Serotype Selection
See how customized AAV serotype selection improved gene delivery in a preclinical study, addressing vector tropism, transduction efficiency, and immune response challenges.

Explore Ready-to-Use Mouse Models

Discover over 18,000 validated mouse strains—including knockout, conditional knockout, and humanized models—covering 20+ research areas such as oncology, neurology, and metabolism. All models are supported by detailed genotype data and guaranteed quality, helping you fast-track discovery with confidence.

You Might Also Be Interested In

AAV Vectors Library

Search and order AAVs by serotype, gene, or function

AI-Powered AAV Discovery

Accelerate gene therapy with AI-optimized AAV capsid engineering and testing

Gene Therapy CRO Platform

AI-guided AAV design and full-spectrum preclinical validation

MouseAtlas Model Library

Search and access curated genetically engineered mouse strains

Ophthalmic CRO Platform

Ocular disease models and IND-ready drug evaluation workflows

Neuroscience CRO Platform

Validated CNS models with behavioral and molecular efficacy data

Workflow

Workflow and Delivery

Cyagen’s AAV packaging service ensures high-purity, high-titer virus production with customizable options tailored for gene therapy and biomedical research. Below is an overview of our streamlined workflow, service specifications, and available serotypes.

Service Comparison & Deliverables

We offer different grades of lentiviral packaging services tailored to various applications, ensuring the highest level of performance and biosafety compliance.

AAV Type	Production Scale	Virus Amount	Titer	Turnaround	QC & Deliverables
Overexpression	Pilot	≥1×10¹² GC	≥1×10¹² GC/mL	5-6 weeks	- Purified AAV particles (selected serotype) - Complimentary control virus - qPCR-based titer quantification - SDS-PAGE & Western blot validation - Endotoxin testing (<10 EU/mL) - Purity validation (≥95%)
Overexpression	Medium	≥5×10¹² GC	≥1×10¹³ GC/mL	5-6 weeks
RNA Interference	Pilot (3+1)	≥1×10¹² GC	≥1×10¹² GC/mL	5-6 weeks
RNA Interference	Medium (3+1)	≥5×10¹² GC	≥1×10¹³ GC/mL	5-6 weeks
Knockout	Pilot	≥1×10¹² GC	≥1×10¹² GC/mL	5-6 weeks
Knockout	Medium	≥5×10¹² GC	≥1×10¹³ GC/mL	5-6 weeks

Workflow & Timeline

Stage	Description	Estimated Time
Plasmid Preparation	Three-plasmid co-transfection system design & optimization with AI-assisted sequence validation.	1 week
AAV Production	293T cell transfection and virus harvesting.	2-3 weeks
Purification	Gradient ultracentrifugation for high-purity AAVs.	1-2 weeks
Quality Control & Validation	Titer quantification, purity assessment, sterility testing.	1-2 weeks
Final Packaging & Delivery	Sterile filtration, cryopreservation, documentation preparation.	1 week

Notes: Total Turnaround: 5-6 weeks (depending on vector type & serotype selection).

FAQs

Citation Database

Molecular Therapy: Methods & Clinical Development, March, 2025

Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing

【Other】

Gut, February, 2025

E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression

【Other】

Cell Death & Disease, February, 2025

Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage

【Other】

Molecular Therapy, February, 2025

Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer

【Other】

Request a Virus Packaging Service Consultation

Get expert guidance for your viral vector production needs. Submit your project details and we'll assist you promptly.

Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:

Yes, I want to receive updates on products, services, and events from Cyagen.

You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.

By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.